Impedimed Ltd (OTCPK:IPDQF)
$ 0.0421 0 (0%) Market Cap: 72.33 Mil Enterprise Value: 57.27 Mil PE Ratio: 0 PB Ratio: 4.21 GF Score: 0/100

Q3 2024 ImpediMed Ltd Activities Report Call Transcript

Apr 30, 2024 / 01:00AM GMT
Release Date Price: $0.04 (-33.05%)
Operator

Thank you for standing by, and welcome to the ImpediMed Q3 results call. (Operator Instructions) I would now like to hand the conference over to Dr. Parmjot Bains, Managing Director and CEO. Please go ahead.

Parmjot Bains
ImpediMed Ltd - Interim Chief Executive Officer, Managing Director, Executive Director

Good morning, and thank you for the opportunity for us to present and discuss our Q3 FY24 results with you. As usual, with me today is McGregor Grant, our Interim CFO and Executive Director. Also joining us today is our Chief Medical Officer, Dr. Steven Chen. On this call, I will provide an overview of the activity for the last quarter.

Dr. Chen will then discuss the updates to the NCCN guidelines and the recent publication of this technology on the National Cancer Institute web page and explain why this is important from pyramid. He will also provide an update on the recent American Society of Breast Surgeons meeting. I will then hand over to Greg to talk through the financials. And after that, we'll open the line for questions.

The

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot